ASCORBIC ACID
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 175.0 | -3.4 | 2 | 6 | 107.0 | 2 | 0.67 |
- CAS
- 50817
- UNII
- PQ6CK8PD0R
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 1 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).
(Browse) Purchasable Analogs in ZINC
Functions of Ascorbic Acid
| Ds - Dietary supplement |
| Misc - Miscellaneous |
| Nutr - Nutrient |
| Pres - Chemical preservative |
Regulatory Status of Ascorbic Acid
| Fs - Substances permitted as optional ingredient in a standardized food. |
Dosages
| Route | Formulation | Per Unit Dose |
|---|---|---|
| An,infiltration | Injection | |
| Caudal Block | Injection | |
| Epidural | Injection | |
| Im - Iv | Injection | 0.2% |
| Inhalation | Aerosol, Metered | 95.95% |
| Inhalation | Aerosol, Spray | 0.11% |
| Inhalation | Solution | 1.02% |
| Intramuscular | Injection | 1% |
| Intravenous | Injection | 12.5%W/V |
| Intravenous | Powder, For Injection Solution | 0.2% |
| Intravenous | Powder, For Injection Solution, Lyophilized | 0.09% |
| Intravenous | Solution, Injection | 0.44% |
| Iv(Infusion) | Injection | 50.4% |
| Iv(Infusion) | Powder, For Injection Solution | |
| Iv(Infusion) | Powder, For Injection Solution, Lyophilized | 48% |
| Nerve Block | Injection | |
| Nerve Block | Solution, Injection | 0.2% |
| Oral | Capsule | 7MG |
| Oral | Capsule, Extended Release | 0.4MG |
| Oral | Concentrate | 0.6% |
| Oral | Powder, For Oral Solution | 5MG |
| Oral | Solution | 0.6% |
| Oral | Suspension | 1% |
| Oral | Suspension, Sustained Action | |
| Oral | Syrup | 0.25% |
| Oral | Tablet | 28.44MG |
| Oral | Tablet, Film Coated | 20MG |
| Rectal | Suppository | 3MG |
| Subcutaneous | Injection | 1% |
| Topical | Gel | 0.3% |
| Topical | Solution | 0.04% |